FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program 2018
07 Mar 2018
Webinar
Key Topics
The Sponsor‘s responsibility in monitoring study conduct
What does the FDA look at when Auditing/Inspecting a study?
The nature of adequate oversight of all staff and non-staff
Components of a sponsor monitoring system beyond SOPs
How do sites prepare for an audit / inspection
The importance of Protocol knowledge in preventing errors
The measures to ensure quality monitoring
Who should Attend
Project Managers
Senior Management
QA/Compliance Persons
CRA Managers
Clinical Research Scientists (PKs, Biostatisticians)
Principal Investigators and Sub Investigators
Clinical Research Associates (CRAs) and Cordinators (CRCs)
Safety Nurses
QA / QC Auditors and Staff
Recruiting Staff
Clinical Research Data Managers
Past Events
FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program 2018 - 07 Mar 2018, Webinar (14194)
FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program 2026
Important
Please, check "FDA Clinical Trial Auditing and the due diligence Companies should conduct as part of their monitoring program" official website for possible changes, before making any traveling arrangements
Event Categories
Health & Medicine: Hospitals & Clinics, Medical device, Medical laboratories, Pharma
